Domicilium reports 18.6% stake in Eloxx

Eloxx Pharmaceuticals disclosed a Schedule 13G showing Domicilium-related entities and Daniel Simon together report beneficial ownership of up to 1,407,138 shares, representing 18.6% of the common stock.

Rhea-AI Filing Summary

Eloxx Pharmaceuticals disclosed a Schedule 13G showing Domicilium-related entities and Daniel Simon together report beneficial ownership of up to 1,407,138 shares, representing 18.6% of the common stock. The filing lists shared voting and dispositive power for those shares and states they are held for advisory clients.

The filing is signed by Daniel Simon as managing member and includes a joint filing agreement among the Domicilium entities.

Insights

Corporate Governance Analyst

Large passive stake disclosed with shared control across related entities.

The filing reports that Domicilium Real Estate Fund III LP and related entities, advised by Domicilium Capital Partners LLC, and Daniel Simon hold shared voting and dispositive power over up to 1,407,138 shares (18.6%).

This is a disclosure of ownership and does not state plans to act as an activist or to change control; subsequent filings would be required for any coordinated actions.

Investor Relations Advisor

Disclosure clarifies beneficial ownership and who signs on behalf of advisory clients.

The report states the securities are directly owned by advisory clients of Domicilium Capital Partners LLC, with only Domicilium Real Estate Fund III LP above the 5% threshold individually.

Investors should watch for any future Schedule 13D or Form 4 that would indicate active trading or change in intentions.

Key Figures

Largest reported holding: 1,407,138 shares Percent of class: 18.6% Fund III reported holding: 1,250,000 shares +1 more

4 metrics

Largest reported holding 1,407,138 shares reported for Domicilium Capital Partners LLC and Daniel Simon

Percent of class 18.6% percent of common stock for Domicilium Capital Partners LLC and Daniel Simon

Fund III reported holding 1,250,000 shares reported for Domicilium Real Estate Fund III LP and its GP

Filing type Schedule 13G passive beneficial ownership disclosure

Key Terms

Schedule 13G, Beneficially owned, Shared dispositive power, Advisory clients

4 terms

Schedule 13G regulatory

"Item 1. | (a) | Name of issuer: Eloxx Pharmaceuticals, Inc."

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned:"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Shared dispositive power financial

"Shared Dispositive Power 1,407,138.00"

Advisory clients regulatory

"All of the securities reported in this are directly owned by advisory clients"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Domicilium report in Eloxx (ELOX)?

The filing reports up to 1,407,138 shares, representing 18.6% of common stock. The figure is shown as shared voting and dispositive power held across Domicilium entities and Daniel Simon.

Who signed the Schedule 13G for ELOX?

Daniel Simon signed the filing in multiple capacities on behalf of the Domicilium entities. The filing also includes a joint filing agreement among the related Domicilium entities.

Are the reported shares directly owned or held for clients?

The filing states the securities are directly owned by advisory clients of Domicilium Capital Partners LLC. Except for Domicilium Real Estate Fund III LP, no single advisory client is stated to exceed 5%.

Does the Schedule 13G indicate active intent to influence Eloxx?

No active intent is stated. The filing discloses beneficial ownership under passive reporting rules; it does not assert plans to seek control or engage in coordinated actions.

Which Domicilium entities are named in the ELOX filing?

The filing names Domicilium Real Estate Fund III LP, Domicilium Real Estate Fund III GP LLC, Domicilium Capital Partners LLC, and individual Daniel Simon as reporting persons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 06:18 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Eloxx Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

29014R103

(CUSIP Number)

04/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 29014R103

1

Names of Reporting Persons

Domicilium Real Estate Fund III LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,250,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,250,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,250,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

16.5 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP Number(s): 29014R103

1

Names of Reporting Persons

Domicilium Real Estate Fund III GP LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,250,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,250,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,250,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

16.5 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 29014R103

1

Names of Reporting Persons

Domicilium Capital Partners LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,407,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,407,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,407,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

18.6 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP Number(s): 29014R103

1

Names of Reporting Persons

Daniel Simon

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,407,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,407,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,407,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

18.6 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Eloxx Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: P.O. Box 274, 10 Court Street, Arlington, MA 02476
Item 2.
(a)	Name of person filing: Domicilium Real Estate Fund III LP Domicilium Real Estate Fund III GP LLC Domicilium Capital Partners LLC Daniel Simon
(b)	Address or principal business office or, if none, residence: Domicilium Real Estate Fund III LP 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Domicilium Real Estate Fund III GP LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Domicilium Capital Partners LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Daniel Simon 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092
(c)	Citizenship: Domicilium Real Estate Fund III LP - Delaware Domicilium Real Estate Fund III GP LLC - Delaware Domicilium Capital Partners LLC - Delaware Daniel Simon - United States
(d)	Title of class of securities: Common Stock, $0.01 par value
(e)	CUSIP Number(s): 29014R103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Domicilium Real Estate Fund III LP - 1,250,000 Domicilium Real Estate Fund III GP LLC - 1,250,000 Domicilium Capital Partners LLC - 1,407,138 Daniel Simon - 1,407,138
(b)	Percent of class: Domicilium Real Estate Fund III LP - 16.5% Domicilium Real Estate Fund III GP LLC - 16.5% Domicilium Capital Partners LLC - 18.6% Daniel Simon - 18.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Domicilium Real Estate Fund III LP - 0 Domicilium Real Estate Fund III GP LLC - 0 Domicilium Capital Partners LLC - 0 Daniel Simon - 0
	(ii) Shared power to vote or to direct the vote: Domicilium Real Estate Fund III LP - 1,250,000 Domicilium Real Estate Fund III GP LLC - 1,250,000 Domicilium Capital Partners LLC - 1,407,138 Daniel Simon - 1,407,138
	(iii) Sole power to dispose or to direct the disposition of: Domicilium Real Estate Fund III LP - 0 Domicilium Real Estate Fund III GP LLC - 0 Domicilium Capital Partners LLC - 0 Daniel Simon - 0
	(iv) Shared power to dispose or to direct the disposition of: Domicilium Real Estate Fund III LP - 1,250,000 Domicilium Real Estate Fund III GP LLC - 1,250,000 Domicilium Capital Partners LLC - 1,407,138 Daniel Simon - 1,407,138
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. All of the securities reported in this Schedule 13G are directly owned by advisory clients of Domicilium Capital Partners LLC. None of those advisory clients, other than Domicilium Real Estate Fund III LP, may be deemed to beneficially own more than 5% of the Common Stock, $0.01 par value.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Domicilium Real Estate Fund III LP

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member of its general partner
Date:	05/04/2026

Domicilium Real Estate Fund III GP LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	05/04/2026

Domicilium Capital Partners LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	05/04/2026

Daniel Simon

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon
Date:	05/04/2026

Exhibit Information

Exhibit A - Joint Filing Agreement